As Johnson & Johnson’s vaccine trial enters phase three, Canaccord Genuity Wealth Management’s Rob Tétrault discusses the market impact.
Business Report
Global News Morning Market & Business Report – Sept. 23, 2020
More Videos
You are viewing an Accelerated Mobile Webpage.
View Original Article